中文 | English
Return
Total: 422 , 1/43
Show Home Prev Next End page: GO
Author:(Xu-dong TANG)

1.Predictive model for severe adverse reaction associated with bevacizumab based on the global trigger tool and machine learning

Yongfei FU ; Xin LONG ; Hongzhen XU ; Jian TANG ; Xiangqing LI ; Yucheng LONG ; Dong QIN

China Pharmacy 2026;37(4):497-503

2.Influence of Leptospira interrogans infection on the expression of autophagy-related proteins Beclin-1,LC3B,and P62 in C3H/HeJ mice

Cheng DU ; Yan TAN ; Ling XIE ; Yuanyuan GU ; Dong TANG ; Xu CHEN

Chinese Journal of Zoonoses 2025;41(8):832-837

3.Association between serum non-HDL-C and cardiovascular disease mortality risk

Baocheng DONG ; Longfei MAO ; Haitao WEI ; Shuxia ZHU ; Xiangping TANG ; Liuting XU ; Lixiang CHAI ; Yelu RUAN ; Shunqin HUANG ; Jianbing WANG

Chinese Journal of Preventive Medicine 2025;59(10):1763-1769

4.Clinical trail of vericiguat combined with sacubitril valsartan sodium in the treatment of patients with heart failure with reduced ejection fraction

Miao-jun WANG ; Shi-ping XU ; Xiao-jin PAN ; Zhi-dong YE ; Yu-fang LIAN ; Jun QIU ; Shao-tang LU ; Sheng-jie ZHOU

The Chinese Journal of Clinical Pharmacology 2025;41(1):6-10

5.Clinicopathological features and surgery-related outcomes of duodenal adenocarcinoma: a multicenter retrospective study

Qifeng XIAO ; Xin WU ; Chunhui YUAN ; Zongting GU ; Xiaolong TANG ; Fanbin MENG ; Dong WANG ; Ren LANG ; Gang ZHAI ; Xiaodong TIAN ; Yu ZHANG ; Enhong ZHAO ; Xiaodong ZHAO ; Feng CAO ; Jingyong XU ; Ying XING ; Jishu WEI ; Shanmiao GOU ; Chengfeng WANG ; Jianwei ZHANG

Chinese Journal of Oncology 2025;47(10):1026-1038

6.Vasovagal syncope patients' experience of emotion management and program needs from the doctor-nurse-patient perspective: a phenomenological research

Yili GAO ; Haiping YU ; Baoxin TANG ; Yanfen DONG ; Ying XU ; Jiawen QIN ; Na LI ; Yongqing ZHANG

Chinese Journal of Modern Nursing 2025;31(4):462-469

7.Unlocking the role of wound microbiome in diabetic, burn, and germ-free wound repair treated by natural and synthetic scaffolds.

Zeyu XU ; Lixiang ZHANG ; Qinghan TANG ; Chenxi YANG ; Xiaotong DING ; Ziyu WANG ; Rizhong HUANG ; Ruihan JIANG ; Joannake MAITZ ; Huaikai SHI ; Xin YAN ; Mei DONG ; Jun CHEN ; Yiwei WANG

Acta Pharmaceutica Sinica B 2025;15(1):611-626

8.Diabetic vascular calcification inhibited by soluble epoxide hydrolase gene deletion via regressing NID2-mediated IGF2-ERK1/2 signaling pathway.

Yueting CAI ; Shuiqing HU ; Jingrui LIU ; Jinlan LUO ; Wenhua LI ; Jiaxin TANG ; Siyang LIU ; Ruolan DONG ; Yan YANG ; Ling TU ; Xizhen XU

Chinese Medical Journal 2025;138(20):2657-2668

9.Clinical trail of vericiguat combined with sacubitril valsartan sodium in the treatment of patients with heart failure with reduced ejection fraction

Miao-jun WANG ; Shi-ping XU ; Xiao-jin PAN ; Zhi-dong YE ; Yu-fang LIAN ; Jun QIU ; Shao-tang LU ; Sheng-jie ZHOU

The Chinese Journal of Clinical Pharmacology 2025;41(1):6-10

10.Clinicopathological features and surgery-related outcomes of duodenal adenocarcinoma: a multicenter retrospective study

Qifeng XIAO ; Xin WU ; Chunhui YUAN ; Zongting GU ; Xiaolong TANG ; Fanbin MENG ; Dong WANG ; Ren LANG ; Gang ZHAI ; Xiaodong TIAN ; Yu ZHANG ; Enhong ZHAO ; Xiaodong ZHAO ; Feng CAO ; Jingyong XU ; Ying XING ; Jishu WEI ; Shanmiao GOU ; Chengfeng WANG ; Jianwei ZHANG

Chinese Journal of Oncology 2025;47(10):1026-1038

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 422 , 1/43 Show Home Prev Next End page: GO